
Surmodics SRDX
Quarterly report 2025-Q2
added 08-08-2025
Surmodics P/B Ratio 2011-2026 | SRDX
Annual P/B Ratio Surmodics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.66 | 4.01 | 4.67 | 4.41 | 5.38 | 5.13 | 7.72 | 3.46 | 3.05 | 3.02 | 2.98 | 3.74 | 3.52 | 1.31 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.72 | 1.31 | 4.08 |
P/B Ratio of other stocks in the Diagnostics research industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
1.47 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
0.532 | - | -17.87 % | $ 25.9 M | ||
|
BioNano Genomics
BNGO
|
0.1 | $ 1.14 | 1.79 % | $ 1.45 M | ||
|
Brainsway Ltd.
BWAY
|
3.17 | $ 24.16 | -1.02 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
1.22 | $ 25.99 | -5.94 % | $ 272 M | ||
|
Aspira Women's Health
AWH
|
6.75 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-1.81 | - | -61.36 % | $ 2.46 M | ||
|
Celcuity
CELC
|
3.45 | $ 108.55 | 2.61 % | $ 4.28 B | ||
|
Biocept
BIOC
|
0.67 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
1.97 | - | - | $ 562 M | ||
|
Check-Cap Ltd.
CHEK
|
-2.99 | - | - | $ 9.42 M | ||
|
Danaher Corporation
DHR
|
1.79 | $ 210.2 | 0.48 % | $ 150 B | ||
|
DarioHealth Corp.
DRIO
|
0.45 | $ 11.26 | - | $ 319 M | ||
|
Chembio Diagnostics
CEMI
|
0.707 | - | 0.22 % | $ 16.8 M | ||
|
Enzo Biochem
ENZ
|
0.00103 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
0.413 | $ 23.36 | 1.17 % | $ 706 M | ||
|
Co-Diagnostics
CODX
|
0.406 | - | - | $ 79.8 M | ||
|
Global Cord Blood Corporation
CO
|
0.0498 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
3.46 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
561 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
1.28 | - | 0.12 % | $ 80.1 M | ||
|
Quest Diagnostics Incorporated
DGX
|
1.18 | $ 206.62 | -1.39 % | $ 22.9 B | ||
|
Castle Biosciences
CSTL
|
1.56 | $ 30.84 | 3.01 % | $ 857 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.32 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
1.99 | $ 18.23 | -5.3 % | $ 980 M | ||
|
DermTech
DMTK
|
0.742 | - | -11.32 % | $ 2.94 M | ||
|
DexCom
DXCM
|
9.29 | $ 72.82 | -0.37 % | $ 28.4 B | ||
|
Interpace Biosciences
IDXG
|
-1.86 | $ 1.74 | - | $ 7.63 M | ||
|
Exact Sciences Corporation
EXAS
|
8.12 | $ 103.35 | -0.1 % | $ 19.5 B | ||
|
Laboratory Corporation of America Holdings
LH
|
2.77 | $ 282.37 | -1.66 % | $ 23.5 B | ||
|
Guardant Health
GH
|
-135 | $ 96.51 | 1.16 % | $ 12.1 B | ||
|
QIAGEN N.V.
QGEN
|
1.84 | - | - | $ 10.6 B | ||
|
Myriad Genetics
MYGN
|
1.11 | $ 4.87 | 9.93 % | $ 451 M | ||
|
Natera
NTRA
|
7.52 | $ 213.14 | 1.72 % | $ 21 B | ||
|
Charles River Laboratories International
CRL
|
2.4 | $ 169.03 | 1.79 % | $ 8.38 B | ||
|
Heska Corporation
HSKA
|
2 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
0.554 | - | -20.0 % | $ 1.06 M | ||
|
ICON Public Limited Company
ICLR
|
1.74 | $ 101.81 | -2.19 % | $ 8.4 B | ||
|
ENDRA Life Sciences
NDRA
|
0.86 | $ 3.81 | -1.28 % | $ 2.05 M | ||
|
Pacific Biosciences of California
PACB
|
2.01 | $ 1.67 | 0.3 % | $ 424 M | ||
|
IDEXX Laboratories
IDXX
|
31.8 | $ 658.84 | 1.48 % | $ 53 B | ||
|
Illumina
ILMN
|
2.6 | $ 122.86 | -0.03 % | $ 19.5 B | ||
|
IQVIA Holdings
IQV
|
4.27 | $ 163.95 | -0.56 % | $ 28.2 B | ||
|
Motus GI Holdings
MOTS
|
0.368 | - | -34.28 % | $ 263 K | ||
|
Koninklijke Philips N.V.
PHG
|
0.995 | $ 31.53 | 0.13 % | $ 20 B | ||
|
Mettler-Toledo International
MTD
|
-1.2 K | $ 1 382.14 | 0.18 % | $ 28.5 B | ||
|
Biodesix
BDSX
|
4.41 | $ 12.79 | -1.77 % | $ 1.66 B | ||
|
Quidel Corporation
QDEL
|
7.93 | $ 23.65 | 7.82 % | $ 996 M | ||
|
Lantheus Holdings
LNTH
|
5.94 | $ 74.97 | 1.85 % | $ 5.19 B | ||
|
Biomerica
BMRA
|
1.75 | $ 2.06 | -1.92 % | $ 4.73 M |